We have also shown the potential biomarker utility of the circulating SFRP4 protein in an independent cohort by demonstrating its differential abundance in plasma from subjects with obesity, prediabetes, and T2DM [16]. The gene discussed is SFRP4; the disease is type 2 diabetes mellitus.